Down's syndrome in pregnant women could be identified through a simple non-invasive blood test, claim researchers who decry the current amniocentesis test with its risk of miscarriage.
But Dutch researchers told a fertility conference that they are on the verge of developing an accurate way of testing the mother's blood for chromosome disorders in the foetus.
High Risk Pregnancy Group Calculator
Medindia offers you a useful calculator to find out if you fall under the high risk pregnant group. Take the precautionary steps and avoid complications during pregnancy.
Advertisement
The test is based on a series of "probes" that attach to specific points on a chromosome.
It is the same technique that is already used to detect problems in foetal DNA in samples taken from the amniotic fluid in the womb.
But the advantage of testing the mother's blood is that it is non-invasive, quick and carries no risks for the foetus.
![APGAR]( "APGAR")
This scoring system is used to identify babies at risk for complications or bad outcome from delivery during the early minutes of their life and determine if any medical intervention is needed immediately.
Delegates at the conference heard that the team have so far successfully identified the male or Y chromosome from the foetus in the mother's blood, proving their technique works.
And they said that the test can be used as early as six-to-eight weeks,.
They are now using the same principle to develop probes to detect the extra chromosome found in Down's syndrome.
It will be tested in women at high risk of an abnormal pregnancy and so already undergoing prenatal screening and invasive tests.
If proven to be accurate, the researchers hope that all women will have access to the blood test within a few years.
Study leader Dr Suzanna Frints, a clinical geneticist at Maastricht University Hospital, says the test could eventually be available for as little as 25 pounds.
Professor Stephen Robson, spokesman for the Royal College of Obstetricians and Gynaecologists, said there are a number of labs around the world working on different techniques for such diagnostic tests.
"It is the holy grail of prenatal diagnosis to try and find a reliable method of diagnosing Down's syndrome and other chromosome abnormalities without doing invasive testing," the BBC quoted him as saying.
The details of the test were presented at the European Society of Human Reproduction and Embryology.
Source: ANI
But the advantage of testing the mother's blood is that it is non-invasive, quick and carries no risks for the foetus.
APGAR
This scoring system is used to identify babies at risk for complications or bad outcome from delivery during the early minutes of their life and determine if any medical intervention is needed immediately.
Advertisement
Delegates at the conference heard that the team have so far successfully identified the male or Y chromosome from the foetus in the mother's blood, proving their technique works.
And they said that the test can be used as early as six-to-eight weeks,.
They are now using the same principle to develop probes to detect the extra chromosome found in Down's syndrome.
It will be tested in women at high risk of an abnormal pregnancy and so already undergoing prenatal screening and invasive tests.
If proven to be accurate, the researchers hope that all women will have access to the blood test within a few years.
Study leader Dr Suzanna Frints, a clinical geneticist at Maastricht University Hospital, says the test could eventually be available for as little as 25 pounds.
Professor Stephen Robson, spokesman for the Royal College of Obstetricians and Gynaecologists, said there are a number of labs around the world working on different techniques for such diagnostic tests.
"It is the holy grail of prenatal diagnosis to try and find a reliable method of diagnosing Down's syndrome and other chromosome abnormalities without doing invasive testing," the BBC quoted him as saying.
The details of the test were presented at the European Society of Human Reproduction and Embryology.
Source: ANI
Down Syndrome
Down Syndrome is a congenital disorder among children commonly born to older mothers. The condition is also known as 'Up syndrome' because of the cheerful persona of the Down children.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.
Link between advanced paternal age and higher risks for reproductive and offspring medical problems has been discovered.